Hydroxynicotinic acid
metaboliteNicotinic acid metabolite depletion in myocardial injury marks impaired NAD+ cycling and cardiomyocyte bioenergetic stress.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencelow
RationaleNiacin metabolite downregulated in myocarditis; reflects NAD+ metabolism disruption in injured myocardium.
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research
Literature evidence(1)
- Metabolic Profiling Reveals Diagnostic Biomarkers for Distinguishing Myocarditis From Acute Myocardial Infarction.Cardiovascular therapeutics · 2025 · PMID 40270589 · doi